A recently uploaded market research study on Global Complement C3 ELISA Kits Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2027 from MarketsandResearch.biz focuses on ...
BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the Phase 3 study of ULTOMIRIS™ (ravulizumab-cwvz), the company’s long-acting C5 complement inhibitor, met its ...